
Ask a doctor about a prescription for FENOFIBRATE PENSA PHARMA 145 mg FILM-COATED TABLETS
Package Leaflet: Information for the User
Fenofibrate Pensa Pharma 145 mg Film-Coated Tablets EFG
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the Package Leaflet
Fenofibrate belongs to a group of medicines known as fibrates. These medicines are used to lower the level of fats (lipids) in the blood. For example, fats known as triglycerides.
Fenofibrate is used, along with a low-fat diet and other non-drug treatments such as exercise and weight loss, to lower the levels of fats in the blood.
Fenofibrate may be used in combination with other medicines (statins), in certain circumstances, when a statin alone does not control the levels of fat in the blood.
Do not take Fenofibrate Pensa Pharmaif:
Do not take fenofibrate if any of the above circumstances apply to you. If you are not sure, consult your doctor or pharmacist before taking this medicine.
Warnings and Precautions
Consult your doctor or pharmacist before starting to take fenofibrate if:
If any of the above circumstances apply to you (or you are unsure), consult your doctor or pharmacist before taking fenofibrate.
Muscle Effects
Stop taking fenofibrate and consult your doctor immediately if you experience:
This is because this medicine can cause muscle problems that can be serious. These problems occur rarely but include inflammation and destruction of muscle. This can cause kidney damage or even death.
Your doctor may perform a blood test to check your muscles before and after starting treatment.
The risk of muscle problems is higher in some patients. In particular, consult your doctor if:
If any of the above circumstances apply to you (or you are unsure), consult your doctor or pharmacist before taking this medicine.
Other Medicines and Fenofibrate Pensa Pharma
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines. In particular, tell your doctor or pharmacist if you are taking any of the following medicines:
If any of the above circumstances apply to you (or you are unsure), consult your doctor or pharmacist before taking fenofibrate.
Pregnancy and Breastfeeding
Driving and Using Machines
This medicine does not affect your ability to drive or use tools or machines.
Fenofibrate Pensa Pharmacontains sucrose
This medicine contains sucrose. If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medicine.
Fenofibrate Pensa Pharmacontains sodium
This medicine contains less than 1 mmol of sodium (23 mg) per film-coated tablet; this is essentially "sodium-free".
Follow exactly the administration instructions of this medicine given by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
Your doctor will determine the suitable dose for you, depending on your condition, current treatment, and personal risk factors.
Taking the Medicine
The film-coated tablet can be taken with or without food at any time of the day.
Remember that, in addition to taking fenofibrate, it is also important that:
How Much to Take
The recommended dose is one film-coated tablet per day.
Patients with Kidney Problems
If you have kidney problems, your doctor may indicate that you take a lower dose. Consult your doctor or pharmacist about this.
Use in Children and Adolescents
The use of fenofibrate is not recommended in children and adolescents under 18 years old.
If you Take More Fenofibrate Pensa Pharmathan you Should
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicology Information Service Telephone 91.562.04.20, indicating the medicine and the amount ingested.
It is recommended to take the package and the package leaflet of the medicine to the healthcare professional.
If you Forget to Take Fenofibrate Pensa Pharma
If you Stop Taking Fenofibrate Pensa Pharma
Do not stop taking this medicine unless your doctor tells you to or unless the tablets make you feel unwell. This is because abnormal levels of fats in the blood require long-term treatment.
If your doctor stops the medicine, do not keep the remaining tablets unless your doctor tells you to.
If you have any other questions about the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Stop taking fenofibrate and consult your doctor immediately, if you notice any of the following serious side effects – you may need urgent medical treatment:
Uncommon:may affect up to 1 in 100 people
Rare:may affect up to 1 in 1,000 people
Not Known:cannot be estimated from the available data
Stop taking fenofibrate and consult your doctor immediately, if you notice any of the above side effects.
Other Side Effects:
Consult your doctor or pharmacist if you experience any of the following side effects:
Common:may affect up to 1 in 10 people
Uncommon:may affect up to 1 in 100 people
Rare:may affect up to 1 in 1,000 people
Not Known:cannot be estimated from the available data
Consult your doctor or pharmacist if you experience any of the above side effects.
Reporting of Side Effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse, even if it is possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Surveillance System for Human Use: www.notificaram.es.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the packaging and on the blister after EXP. The expiry date is the last day of the month stated.
This medicine does not require any special storage conditions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
In the core: sodium lauryl sulfate, hypromellose, sucrose, pregelatinized maize starch, microcrystalline cellulose, crospovidone, colloidal anhydrous silica, sodium fumarate, and stearic acid.
In the film coating: poly(vinyl alcohol), titanium dioxide (E 171), macrogol/polyethylene glycol (E1521), talc.
Appearance of the Product and Contents of the Pack
Fenofibrate Pensa Pharma 145 mg film-coated tablets EFG are presented in the form of white to off-white, oval, biconvex film-coated tablets, with dimensions of 19.1 mm x 9 mm, with one face engraved with "RH 38" and the other face flat.
The film-coated tablets are presented in PVC/PE/PVDC/Al blisters, in boxes containing 30, 90, and 100 film-coated tablets.
Not all pack sizes may be marketed.
Marketing Authorization Holder
Towa Pharmaceutical, S.A.
C/ de Sant Martí, 75-97
08107 Martorelles (Barcelona)
Spain
Manufacturer
Sun Pharmaceutical Industries Europe B.V.
Polarisavenue 87
2132JH Hoofddorp
Netherlands
or
Terapia S.A.
Str. Fabricii nr. 124
Cluj-Napoca, 400632
Romania
This medicine is authorized in the Member States of the EU under the following names:
Germany Fenofibrat SUN 145 mg filmtabletten
Spain Fenofibrato pensa pharma 145 mg comprimidos recubiertos con película EFG
France Fenofibrate SUN 145 mg comprimé pelliculé
Italy Fenofibrato Pensa Pharma
Romania Fenofibrat Terapia 145 mg comprimate filmate
Date of Last Revision of this Leaflet:February 2022
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es
The average price of FENOFIBRATE PENSA PHARMA 145 mg FILM-COATED TABLETS in December, 2025 is around 4.34 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for FENOFIBRATE PENSA PHARMA 145 mg FILM-COATED TABLETS – subject to medical assessment and local rules.